TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
8.61
-0.03 (-0.35%)
At close: Dec 5, 2025, 4:00 PM EST
8.75
+0.14 (1.63%)
After-hours: Dec 5, 2025, 4:10 PM EST
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $7.90 million as of December 5, 2025. Its market cap has increased by 38.57% in one year.
Market Cap
7.90M
Enterprise Value
5.06M
1-Year Change
38.57%
Ranking
Category
Stock Price
$8.61
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $7.90M, a decrease of -83.51%. That is a compound annual growth rate of -33.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 7.90M | 236.48% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |